InvestorsHub Logo
Followers 14
Posts 1421
Boards Moderated 0
Alias Born 06/10/2012

Re: JokersWild12 post# 657

Wednesday, 01/29/2020 2:58:43 PM

Wednesday, January 29, 2020 2:58:43 PM

Post# of 853
Remember my thought of ETNI used for new NGIO spin off from GNBT.The possibility, although very slim, is still alive.I believe the spin off is to happen first quarter of 2020. I am guessing around 400 trading shell companies on otc.I know this would be like winning the lottery, but with the lack of anything happening with ETNI leads me to entertain this.
NGIO would list on nasdaq with minimum $ 2.00 share price.NGIO may have authorized shares from 100 M to 300 M.

MIRAMAR, Fla., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced a merger transaction with a public company that is DTC eligible and current with its SEC filings to serve as a vehicle for the quotation of the common stock of its subsidiary NuGenerex Immuno-Oncology (NGIO) as an independent, publicly traded company.